Comparison of the sedative effect of Remifentanil and Dexmidetomidine
Phase 3
Recruiting
- Conditions
- Patients undergoing venous arterial fistula implantation.
- Registration Number
- IRCT20200502047269N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Age group 19 to 60 years
Patients with stable hemodynamic status
Exclusion Criteria
Patients with a history of cardiovascular abnormalities
Patients with a history of chronic diseases such as liver disease
Patients with a history of allergies to anesthetics, including opioids
Patients with a history of opium use
Pregnant or lactating women
Recent respiratory tract infection
Severe bronchopulmonary disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain score. Timepoint: At the moment after the operation and also every half an hour, up to two hours after the operation. Method of measurement: Use of Visual Analogue Scale (VAS) scoring system.
- Secondary Outcome Measures
Name Time Method ausea and vomiting. Timepoint: After surgery. Method of measurement: Observation.;Hypertension. Timepoint: After surgery. Method of measurement: Mercury barometer.;Oxygen saturation. Timepoint: After surgery. Method of measurement: Pulse oximetry.;Tachycardia and bradycardia. Timepoint: After surgery. Method of measurement: Monitoring.